Is genetic testing necessary before using larotrectinib?

Larotrectinib is a targeted therapy drug mainly used to treat tumors with positive TRK gene fusion (Tropomyosin Receptor Kinase). The use of this drug has clear gene targeting requirements, that is, it is specifically effective against tumors carrying TRK gene fusions. Therefore, before starting to use larotrectinib, it is very important to conduct genetic testing to help doctors confirm whether the patient is eligible for the drug.

Gene testing can determine whether a patient is suitable for larotrectinib by detecting the presence or absence of TRK gene fusion in tumor tissue. TRKGene fusion is a genetic rearrangement event that results in activation of TRK receptors, thereby promoting tumor growth and spread. Larotrectinib achieves anti-tumor effects by inhibiting the tyrosine kinase activity of the TRK receptor and blocking the signaling pathway. Therefore, only those patients with tumors diagnosed as positive for TRK gene fusion can benefit from larotrectinib treatment.

Genetic testing not only helps screen patients for indications, but also avoids unnecessary treatments and side effects. For patients who do not carry the TRK gene fusion, the use of larotrectinib not only has limited effect, but may also increase the risk of side effects. Therefore, genetic testing is an important step in determining the suitability of larotrectinib treatment and helps doctors develop personalized treatment plans for patients.

Currently, genetic testing can typically be performed through tumor tissue biopsies, blood samples, or other molecular diagnostic methods. Before receiving larotrectinib, patients should discuss the need for genetic testing with their physician. Although genetic testing may require time and expense, it is a critical step in ensuring the effectiveness of treatment and avoiding ineffective treatments. In general, genetic testing before using larotrectinib is necessary to help patients get the most effective treatment.

Reference materials:https://www.vitrakvi.com/